Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/29261
Tüm üstveri kaydı
Dublin Core AlanıDeğerDil
dc.date.accessioned2022-10-31T06:40:25Z-
dc.date.available2022-10-31T06:40:25Z-
dc.date.issued2007-04-24-
dc.identifier.citationHamurtekin, E. vd. (2007). "Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats". Neuroscience Letters, 420(2), 116-121.en_US
dc.identifier.issn0304-3940-
dc.identifier.issn1872-7972-
dc.identifier.urihttps://doi.org/10.1016/j.neulet.2007.04.058-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0304394007005095-
dc.identifier.urihttp://hdl.handle.net/11452/29261-
dc.description.abstractCytidine-5'-diphosphate choline (CDP-choline; citicoline) is an essential endogenous compound normally produced by the organism and is a source of cytidine and choline. Our recent studies on acute pain models demonstrate that intracerebroventricularly administered CDPcholine produces antinociception via supraspinal alpha-7 nicotinic acetylcholine receptors-mediated mechanism in rats. However, it remains to be elucidated which other supraspinal mechanisms are involved in the antinociceptive effect of CDP-choline. In this study, we investigated the role of the supraspinal opioidergic, GABAergic, alpha-adrenergic and serotonergic receptors in CDP-choline-induced antinociception. The antinociceptive effect of CDP-choline was evoked by the intracerebroventricular (i.c.v.) administration. Two different pain models were utilized: thermal paw withdrawal test and mechanical paw pressure test. The i.c.v. administration of CDP-choline (0.5, 1.0 and 2.0 mu mol) produced dose-dependent antinociception. Non-specific opioid receptor antagonist naloxone (10 mu g; i.c.v.) and GABA(B) receptor antagonist CGP-35348 (20 mu g; i.c.v.) pretreatments inhibited the antinociceptive effects of CDP-choline (1.0 mu mol; i.c.v.). In contrast, the alpha-1 adrenergic receptor antagonist prazosin (20 mu g; i.c.v.), alpha-2 adrenergic receptor antagonist yohimbine (30 mu g; i.c.v.) and non-specific scrotonin receptor antagonist methysergide (20 mu g; i.c.v.) pretreatments had no effect on CDP-choline-induced antinociception in the thermal paw withdrawal test and in the mechanical paw pressure test. Therefore, it can be postulated that i.c.v. administered CDP-choline exerts antinociceptive effect mediated by supraspinal opioid and GABAB receptors in acute pain models. Furthermore, supraspinal alpha-adrenergic and serotonergic receptors do not appear to be involved in the antinociceptive effect of CDP-choline.en_US
dc.language.isoenen_US
dc.publisherElsevier Irelanden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGABA receptorsen_US
dc.subjectNicotinic acetylcholine-receptorsen_US
dc.subjectAlpha-7 nicotinic receptorsen_US
dc.subjectAntinociceptionen_US
dc.subjectCDP-cholineen_US
dc.subjectOpioid receptorsen_US
dc.subjectPainen_US
dc.subjectMorphine-induced antinociceptionen_US
dc.subjectAnalgesic activityen_US
dc.subjectAgonistsen_US
dc.subjectReleaseen_US
dc.subjectAntagonistsen_US
dc.subjectModulationen_US
dc.subjectMechanismsen_US
dc.subjectCiticolineen_US
dc.subjectDiversityen_US
dc.subjectNeurosciences & neurologyen_US
dc.subject.meshAnalgesicsen_US
dc.subject.meshAcute diseaseen_US
dc.subject.meshAdrenergic alpha-antagonistsen_US
dc.subject.meshAnimalsen_US
dc.subject.meshEfferent oathwaysen_US
dc.subject.meshReceptors, GABA-Ben_US
dc.subject.meshBrainen_US
dc.subject.meshCytidine diphosphate cholineen_US
dc.subject.meshDisease models, animalen_US
dc.subject.meshGABA antagonistsen_US
dc.subject.meshReceptors, GABAen_US
dc.subject.meshInjections,intraventricularen_US
dc.subject.meshMaleen_US
dc.subject.meshReceptors,adrenergic, alphaen_US
dc.subject.meshNarcotic antagonistsen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, sprague-dawleyen_US
dc.subject.meshNociceptorsen_US
dc.subject.meshPainen_US
dc.subject.meshPain measurementen_US
dc.subject.meshPain thresholden_US
dc.subject.meshReceptors, opioiden_US
dc.subject.meshReceptors, serotoninen_US
dc.subject.meshSerotonin antagonistsen_US
dc.titlePossible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in ratsen_US
dc.typeArticleen_US
dc.identifier.wos000247405500005tr_TR
dc.identifier.scopus2-s2.0-34249330701tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Anabilim Dalı.tr_TR
dc.identifier.volume420tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalNeuroscience Lettersen_US
dc.contributor.buuauthorHamurtekin, Emre-
dc.contributor.buuauthorBağdaş, Deniz-
dc.contributor.buuauthorGürun, M. Sibel-
dc.contributor.researcheridAAG-8716-2019tr_TR
dc.identifier.pubmed17531379tr_TR
dc.subject.wosNeurosciencesen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid8717648500tr_TR
dc.contributor.scopusid15062425700tr_TR
dc.contributor.scopusid55664349700tr_TR
dc.subject.scopusCiticoline; Neuroprotective Agents; Glycerylphosphorylcholineen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeAnalgesiaen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeAnimal modelen_US
dc.subject.emtreeAntinociceptionen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeExperimental modelen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreeSerotonin antagonisten_US
dc.subject.emtreeMechanical stimulationen_US
dc.subject.emtreePainen_US
dc.subject.emtreeOpiate antagonisten_US
dc.subject.emtreeRaten_US
dc.subject.emtreeMethysergideen_US
dc.subject.emtree3 aminopropyl(diethoxymethyl)phosphinic aciden_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeThermal stimulationen_US
dc.subject.emtreeAlpha adrenergic receptoren_US
dc.subject.emtreeCiticolineen_US
dc.subject.emtree4 aminobutyric acid B receptoren_US
dc.subject.emtree4 aminobutyric acid B receptor blocking agenten_US
dc.subject.emtree4 aminobutyric acid receptoren_US
dc.subject.emtreeAlpha 1 adrenergic receptoren_US
dc.subject.emtreeAlpha 1 adrenergic receptor blocking agenten_US
dc.subject.emtreeAlpha 2 adrenergic receptoren_US
dc.subject.emtreeAlpha 2 adrenergic receptor blocking agenten_US
dc.subject.emtreeNaloxoneen_US
dc.subject.emtreeOpiate receptoren_US
dc.subject.emtreePrazosinen_US
dc.subject.emtreeSerotonin receptoren_US
dc.subject.emtreeYohimbineen_US
Koleksiyonlarda Görünür:PubMed
Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.